ClinicalTrials.Veeva

Menu
S

Sanatorio Parque | Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pembrolizumab
MK-1084
Docetaxel
MK-6482
Platinum
Enzalutamide
Sotatercept
MK-3475A±MK-1084
Zanzalintinib
Atezolizumab

Parent organization

This site is a part of Sanatorio Parque

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 11 total trials
Locations recently updated

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

Researchers are looking for new ways to treat advanced renal cell carcinoma (RCC).A standard (usual) treatment for certain people with RCC is belzuti...

Enrolling
Carcinoma, Renal Cell
Drug: Placebo
Drug: Zanzalintinib

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation...

Enrolling
Rectal Adenocarcinoma
Colon Adenocarcinoma
Drug: Leucovorin/levofolinate calcium
Drug: 5-Fluorouracil
Locations recently updated

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood t...

Enrolling
Pulmonary Arterial Hypertension
Biological: Sotatercept

This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in partici...

Enrolling
Advanced Solid Tumors
Biological: cetuximab
Drug: carboplatin
Locations recently updated

This is a phase 3, randomized, double-blind study of adjuvant calderasib plus subcutaneous pembrolizumab and berahyaluronidase alfa (MK-3475A) versus...

Enrolling
Non-small Cell Lung Cancer
Drug: Calderasib
Drug: Placebo

This study will evaluate the combination of a fixed dose pembrolizumab/vibostolimab co-formulation (MK-7684A) with etoposide/platinum chemotherapy fo...

Active, not recruiting
Small Cell Lung Carcinoma
Drug: Cisplatin
Biological: Atezolizumab

The purpose of this study is to assess the efficacy and safety of the combination of pembrolizumab (MK-3475) and enzalutamide in the treatment of men...

Active, not recruiting
Prostatic Neoplasms
Drug: Placebo
Biological: Pembrolizumab

Researchers are looking for new ways to treat people with locally advanced non-small cell lung cancer (NSCLC). The goal of this study is to learn if...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: carboplatin
Radiation: thoracic radiotherapy

Trial sponsors

Merck Sharp & Dohme (MSD) logo
Acceleron Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems